Sectors & IndustriesIndustrialsShell Companies

Best Shell Company Stocks to Buy Now (2026)

Top shell company stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best shell company stocks to buy now. Learn More.

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best shell company stocks to buy right now are:

Frazier Life Sciences Acquisition II (NASDAQ:FLSC) is the #1 top shell company stock out of 313 with a Zen Rating of C. Stocks with a rating of C have had an average return of +5.11% per year. Learn more.

The Component Grade breakdown for Frazier Life Sciences Acquisition II (NASDAQ:FLSC) is: Value: C, Growth: C, Momentum: C, Sentiment: C, Safety: C, Financials: C, and AI: C.

Frazier Life Sciences Acquisition II (NASDAQ:FLSC) has a Due Diligence Score of 4, which is -4 points lower than the shell company industry average of 8.

FLSC passed 1 out of 33 due diligence checks and has weak fundamentals.

Cohen Circle Acquisition II (NASDAQ:CCII) is the #2 top shell company stock out of 313 with a Zen Rating of C. Stocks with a rating of C have had an average return of +5.11% per year. Learn more.

The Component Grade breakdown for Cohen Circle Acquisition II (NASDAQ:CCII) is: Value: C, Growth: C, Momentum: C, Sentiment: C, Safety: C, Financials: C, and AI: C.

Cohen Circle Acquisition II (NASDAQ:CCII) has a Due Diligence Score of 10, which is 2 points higher than the shell company industry average of 8.

CCII passed 3 out of 33 due diligence checks and has weak fundamentals. Cohen Circle Acquisition II has seen its stock return 0.1% over the past year, underperforming other shell company stocks by -3 percentage points.

American Exceptionalism Acquisition A (NYSE:AEXA) is the #3 top shell company stock out of 313 with a Zen Rating of C. Stocks with a rating of C have had an average return of +5.11% per year. Learn more.

The Component Grade breakdown for American Exceptionalism Acquisition A (NYSE:AEXA) is: Value: C, Growth: C, Momentum: C, Sentiment: C, Safety: A, Financials: C, and AI: C.

American Exceptionalism Acquisition A (NYSE:AEXA) has a Due Diligence Score of 4, which is -4 points lower than the shell company industry average of 8.

AEXA passed 1 out of 33 due diligence checks and has weak fundamentals. American Exceptionalism Acquisition A has seen its stock lose -5.86% over the past year, underperforming other shell company stocks by -9 percentage points.

100% of shell company stocks rated by analysts are a strong buy right now. On average, analysts expect shell company stocks to rise by 103.31% over the next year.

0% of shell company stocks have a Zen Rating of A (Strong Buy), 0% of shell company stocks are rated B (Buy), 72.22% are rated C (Hold), 27.78% are rated D (Sell), and 0% are rated F (Strong Sell).

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued shell company stocks right now are:

Spaccircle Acquisition (NASDAQ:SCQCU) is the most undervalued shell company stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Spaccircle Acquisition has a valuation score of 0, which is -6 points higher than the shell company industry average of 6. It passed 0 out of 7 valuation due diligence checks.

Frazier Life Sciences Acquisition II (NASDAQ:FLSC) is the second most undervalued shell company stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Frazier Life Sciences Acquisition II has a valuation score of 0, which is -6 points higher than the shell company industry average of 6. It passed 0 out of 7 valuation due diligence checks.

Eqv Ventures Acquisition II (NYSE:EVAC) is the third most undervalued shell company stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Eqv Ventures Acquisition II has a valuation score of 14, which is 8 points higher than the shell company industry average of 6. It passed 1 out of 7 valuation due diligence checks.

Eqv Ventures Acquisition II's stock has gained 3.6% in the past year. It has overperformed other stocks in the shell company industry by 1 percentage points.

Shell company stocks were down -0.02% in the last day, and down -0.38% over the last week.

We couldn't find a catalyst for why shell company stocks are down.